...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: "57% relative risk reduction of MACE in patients with diabetes mellitus (DM) and CVD..."

 Growacet, 

Yes, that abstract was presented at three different meetings earlier this year including American Diabetes Association. See this message and thread. The 57% RRR is from Phase 2 post-hoc analysis, not BETonMACE.

BearDownAZ 

Share
New Message
Please login to post a reply